In Brief: Sanofi Diagnostics Pasteur
This article was originally published in The Gray Sheet
Executive Summary
Sanofi Diagnostics Pasteur: Releases myoglobin assay for use on its Access automated immunoassay system. The test is a "paramagnetic-particle, chemiluminescent immunoassay for the quantitative determination of myoglobin levels in human serum or plasma EDTA," Sanofi says. The myoglobin test is the second of three cardiac assays planned for inclusion on the Access. Sanofi launched its Access CK-MB test earlier this fall ("The Gray Sheet" Oct. 16, In Brief). The firm is planning to launch a troponin-I test in 1996...